Research Overview of Metformin Hydrochloride
Okamet 500mg represents a pharmaceutical-grade formulation of metformin hydrochloride manufactured by Cipla for in-vitro laboratory research applications. Metformin hydrochloride is a biguanide compound extensively studied for its effects on cellular energy metabolism through AMP-activated protein kinase (AMPK) pathway activation. Research teams at Stroid UK Shop investigate this compound’s mechanisms in glucose homeostasis studies and metabolic pathway analysis. Each tablet contains 500mg of active metformin hydrochloride, providing consistent dosing for experimental protocols requiring precise compound administration in laboratory settings.
Laboratory Applications and Research Mechanisms
Scientific literature demonstrates metformin’s primary mechanism involves AMPK activation, leading to enhanced glucose uptake in muscle tissue and reduced hepatic glucose production in experimental models. Researchers studying metabolic modulators examine how this compound influences mitochondrial respiratory complex I inhibition and subsequent cellular energy status. Laboratory investigations focus on metformin’s ability to modulate mTOR signalling pathways, autophagy mechanisms, and cellular senescence processes. Research applications extend to studying its anti-inflammatory properties through NF-κB pathway inhibition in cellular models. Teams also investigate potential longevity-related mechanisms, examining how metformin affects NAD+/NADH ratios and sirtuin activity in experimental preparations. These comprehensive research protocols help scientists understand metabolic regulation at the molecular level.
Product Specifications and Laboratory Data
| Parameter | Specification |
|---|---|
| Active Ingredient | Metformin Hydrochloride |
| Strength per Tablet | 500mg |
| Manufacturer | Cipla Pharmaceuticals |
| CAS Number | 1115-70-4 |
| Molecular Formula | C₄H₁₂ClN₅ |
| Molecular Weight | 165.62 g/mol |
| Storage Conditions | Room temperature, dry environment |
| Formulation | Pharmaceutical tablet |
Researchers comparing metformin with other metabolic compounds often examine selective androgen receptor modulators for comprehensive metabolic studies. Advanced research protocols may incorporate peptide compounds alongside metformin to study complex metabolic interactions. The pharmaceutical-grade formulation ensures consistent results across multiple experimental replications, with each tablet providing standardised compound delivery for laboratory protocols.
Research Compliance and Laboratory Use
Okamet 500mg tablets are supplied exclusively for in-vitro laboratory research and educational purposes. This product is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Research institutions must ensure proper handling procedures, appropriate storage conditions, and compliance with local regulations governing research compound usage. All experimental protocols should follow established laboratory safety guidelines and institutional review board approvals where applicable.
